Back to peptide library

Longevity peptide information

Epithalon

Epithalon is a longevity-support peptide used within IPS for healthy-aging, sleep-quality, recovery, cellular health, and long-term healthspan goals.

Longevity support focusClinical review required

The Science

What is Epithalon?

Epithalon, also known as Epitalon, is a synthetic tetrapeptide made of four amino acids: alanine, glutamic acid, aspartic acid, and glycine.

Longevity research connects Epithalon with the pineal gland, cellular-aging pathways, telomere biology, sleep rhythms, and healthspan-support strategies.

Telomeres are protective caps at the ends of chromosomes that naturally shorten as cells divide over time. Telomere length and cellular senescence are important areas of aging research, and Epithalon has been studied for its relationship with telomerase activity and cellular-aging pathways.

Within IPS, Epithalon is used as a longevity-support option for patients focused on healthy aging, sleep quality, recovery, cellular health, and long-term healthspan goals. It is not presented as an anti-aging cure or a guarantee of biological age reversal.

IPS clinical context

  • Healthy-aging and long-term healthspan goals
  • Sleep quality, circadian rhythm, and recovery patterns
  • Cellular-health and longevity-support planning
  • Medical history, cancer history, medications, hormones, and risk profile
  • Fit with nutrition, training, sleep, metabolic health, and preventive care

Who it may fit

Epithalon clinical considerations.

Epithalon fits best when healthy-aging goals overlap with sleep quality, recovery, cellular health, and long-term healthspan planning.

Injectable

Epithalon

A longevity-support option for patients focused on healthy aging, sleep quality, recovery, cellular health, and long-term healthspan goals.

Clinical context

Healthy Aging + Sleep Recovery

IPS evaluates Epithalon in the context of sleep patterns, recovery demands, metabolic health, hormone status, age-related goals, and overall wellness planning.

Clinical review

Longevity Screening

Candidacy should be evaluated alongside medical history, cancer history, current medications, hormone status, sleep quality, and overall risk profile.

How It Works

How Epithalon fits healthy-aging and healthspan planning.

IPS uses Epithalon within a broader longevity strategy focused on sleep quality, recovery capacity, cellular health, metabolic function, hormone balance, nutrition, strength training, and long-term preventive-health planning.

Telomere biology

Epithalon is studied in longevity medicine for its relationship to telomerase activity, telomere maintenance, and cellular-aging pathways.

Cellular aging support

Telomeres are protective caps at the ends of chromosomes that naturally shorten over time. Epithalon is used within IPS as part of a healthy-aging strategy focused on cellular health, recovery, and long-term healthspan goals.

Sleep and circadian rhythm

Because Epithalon is connected to pineal-gland and circadian-rhythm research, IPS evaluates sleep quality, recovery, hormone balance, and rhythm disruption when determining program fit.

Cellular stress response

Longevity planning also considers antioxidant defense, cellular stress response, immune resilience, recovery capacity, and the patient’s broader health context.

Process

How Epithalon care works at IPS.

01

Longevity Review

Review age, goals, sleep, recovery, family history, metabolic health, medications, and preventive-care priorities.

02

Clinical Screening

Screen cancer history, active medical conditions, hormone context, pregnancy-related factors, and lab needs.

03

Protocol Design

If appropriate, your clinician reviews expectations, monitoring, and follow-up.

04

Follow-Up

Follow-up tracks tolerance, sleep, recovery, energy, and whether the protocol should be adjusted or cycled.

Safety & candidacy

Longevity-support peptides require careful screening.

Epithalon is not presented as an anti-aging cure or a guarantee of biological age reversal. IPS evaluates medical history, cancer history, medications, hormone status, sleep quality, labs when appropriate, and overall risk profile before determining program fit.

Common effects Injection-site irritation, headache, fatigue, vivid dreams, sleep-pattern changes, or temporary symptom shifts may occur.
Clinical context Healthspan goals should be evaluated alongside labs, sleep, metabolic markers, fitness, nutrition, and preventive care.
Medication review Hormone therapy, sleep medications, psychiatric medications, immune therapies, and supplements should be disclosed.
No guarantees Response varies, and Epithalon is not intended to diagnose, treat, cure, or prevent disease.

Questions

Frequently asked.

How does IPS evaluate Epithalon?

IPS evaluates Epithalon in the context of healthy-aging goals, sleep quality, recovery, hormone status, medical history, current medications, cancer history, and overall risk profile before determining whether it fits the care plan.

How is Epithalon commonly administered?

Epithalon is commonly used as an injectable peptide option. IPS evaluates candidacy, expectations, timing, monitoring, and how it fits within a broader healthspan plan.

Is Epithalon an anti-aging cure?

No. Epithalon is not an anti-aging cure and does not guarantee biological age reversal. It is used as a longevity-support option within a broader IPS healthspan plan.

Can it be combined with NAD+ or other peptides?

Yes. Epithalon can be combined with NAD+ or other longevity-support options when appropriate. IPS evaluates current therapies, labs, goals, tolerance, medical history, and safety considerations before combining protocols.

Why IPS is different

Not gray market. Not research-only. Not direct-to-consumer peptide kits.

Many consumers encounter products online labeled for research use only, not for human consumption, or laboratory chemicals. Those labels matter because they are not intended for patient care.

RESEARCH USE ONLYNOT FOR HUMAN CONSUMPTIONLABORATORY CHEMICALS

Products marketed online

  • May be labeled research use only
  • May be labeled not for human consumption
  • May be marketed as laboratory chemicals
  • May not include patient-specific documentation
  • May not involve provider review

The IPS approach

  • Consultation before recommendation
  • Provider review
  • Personalized recommendations
  • Medical oversight
  • Ongoing guidance and support
Important distinction

A product mixed at home from an online powder and labeled research use only is fundamentally different from care that begins with consultation, provider review, appropriate prescribing, and ongoing clinical guidance.

Annual Membership

Wholesale-Style Member Pricing

12-month IPS members receive access to preferred pricing on eligible peptide programs after consultation and medical review.

12-month membership requiredMember pricing reviewed during consultClinical review before any plan
Ask About Membership Pricing

Contact

Ask IPS about Epithalon eligibility.

Send your details and IPS can follow up about consultation scheduling and next steps.

Medical noteThis page is informational and is not intended to diagnose, treat, cure, or prevent disease. Peptide decisions require qualified clinical care.